Estimations des analystes de Wall Street pour Aprea Therapeutics, Inc. (APRE): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.08 | ||
| 2026-08-12 | $-0.07 | $-0.18 | +60.6% |
| 2026-05-13 | $-0.22 | $-0.23 | +4.3% |
| 2026-03-16 | $-0.32 | $-0.38 | +15.8% |
| 2025-11-12 | $-0.47 | $-0.11 | -327.3% |
| 2025-08-12 | $-0.53 | $-0.77 | +31.2% |
| 2025-05-14 | $-0.66 | $-0.65 | -0.9% |
| 2025-03-25 | $-0.49 | $-0.69 | +29.0% |
Ratios de valorisation
| Prix / Valeur comptable | 0.41 |
| EV / EBITDA | 0.72 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | 0 | 0 | $583231 | $1.5M | 0 |
| Coût des Ventes | $7932 | $8316 | $170254 | $229610 | $271677 | $16.4M | $7052 | $9.4M | 0 |
| Marge Brute | -$7932 | -$8316 | -$170254 | -$229610 | -$271677 | -$16.4M | $576179 | -$7.9M | 0 |
| R&D | $13.4M | $14.2M | $21.0M | $37.9M | $23.9M | $92.4M | $7.6M | $9.4M | $7.0M |
| Frais Généraux | $2.5M | $2.3M | $8.4M | $14.9M | $13.6M | $21.0M | $8.4M | $6.5M | $6.5M |
| Charges Opérationnelles | $15.9M | $16.5M | $29.4M | $52.8M | $37.2M | $97.0M | $16.0M | $6.5M | $13.2M |
| Résultat Opérationnel | -$15.9M | -$16.5M | -$29.5M | -$52.8M | -$37.4M | -$113.4M | -$15.5M | -$14.3M | -$13.2M |
| EBITDA | -$15.2M | -$15.5M | -$27.9M | -$53.2M | -$36.9M | -$37.4M | -$14.3M | -$12.9M | -$12.6M |
| Charges d'Intérêt | $15 | $182 | $156351 | $222652 | 0 | $448667 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$15.2M | -$15.5M | -$28.1M | -$53.5M | -$37.1M | -$112.7M | -$14.3M | -$13.0M | -$12.6M |
| Impôts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$15.2M | -$15.5M | -$28.1M | -$53.9M | -$36.5M | -$112.7M | -$14.3M | -$13.0M | -$12.6M |
| BPA | $-21.58 | $-22.06 | $-26.28 | $-50.61 | $-34.88 | $-1359.79 | $-3.95 | $-2.35 | $-1.93 |
| BPA Dilué | $-21.58 | $-22.06 | $-26.28 | $-50.61 | $-34.88 | $-1359.79 | $-3.95 | $-2.35 | $-1.93 |
| Actions en Circulation (Diluées) | $703783 | $703783 | $1.0M | $1.1M | $1.1M | $82852 | $3.6M | $5.5M | $6.5M |
Prix
| Prix | $0.73 |
| Capitalisation | $9M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ACXP · ADIL · APVO · BCDA · CELZ · GLTO · HCWB
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de APRE: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions